Strange that neither FDA nor Pfizer is not saying:

"We have no randomized evidence that bivalent boosters lower severe disease at any age, and the upper bound absolute risk reduction in young men will surely be smaller than their absolute risk of myocarditis"#VRBPAC pic.twitter.com/mY0I6J4tkF

— Vinay Prasad MD MPH (@VPrasadMDMPH) January 26, 2023